apollo
0
Written By Bayyarapu Mahesh Kumar , M Pharmacy
Last Updated Jan 1, 2025 | 9:32 AM IST

Vectibix 100 mg Infusion 5 ml is used to treat Metastatic colorectal cancer (mCRC). It contains Panitumumab, which works by slowing or stopping the growth of cancer cells. As a result, it prevents the cancer from spreading. This medication may cause fetal harm when administered to a pregnant woman. Before beginning treatment, discuss effective contraception with your healthcare professional. Inform them immediately if you or your partner become pregnant while undergoing therapy. Breastfeeding is not recommended while taking Panitumumab.

Read more
Prescription drug
 Trailing icon
Prescription drug

Whats That

tooltip
Consult Doctor

Synonym :

MONOCLONAL ANTIBODIES

Composition :

PANITUMUMAB-100MG

Consume Type :

PARENTERAL

Return Policy :

3 Days Returnable

Expires on or after :

Jan-27

About Vectibix 100 mg Infusion 5 ml

Vectibix 100 mg Infusion 5 ml belongs to a class of monoclonal antibodies. It is used alone or with other anticancer medicines to treat wild-type RAS metastatic colorectal cancer (mCRC). Metastatic colorectal cancer (mCRC) is a type of cancer of the colon or rectum that has spread to other areas of the body.

Vectibix 100 mg Infusion 5 ml contains Panitumumab, which works by slowing or stopping the growth of cancer cells. As a result, it prevents the cancer from spreading.

Vectibix 100 mg Infusion 5 ml will be administered under the supervision of a physician qualified by training and an experienced oncologist. The most frequent side effects of Vectibix 100 mg Infusion 5 ml when taken with other chemotherapy medications include diarrhea, paronychia (nail inflammation), fatigue, nausea, and diarrhea; stomatitis (oral mucosal inflammation and redness), mucosal inflammation, asthenia (abnormal physical weakness), anorexia, hypomagnesemia (an electrolyte disturbance), hypokalemia, rash, skin rash, itchiness, and dry skin. You should talk to your doctor if these side effects persist or worsen.

Notify your doctor of any food or medication allergies or hypersensitivity reactions before taking the Vectibix 100 mg Infusion 5 ml. Vectibix 100 mg Infusion 5 ml may cause fetal harm when administered to a pregnant woman. Before beginning treatment, discuss effective contraception with your healthcare professional. Inform them immediately if you or your partner become pregnant while undergoing therapy. Breastfeeding is not recommended while taking panitumumab.

Uses of Vectibix 100 mg Infusion 5 ml

Treatment of Metastatic colorectal cancer (mCRC)

Medicinal Benefits

Vectibix 100 mg Infusion 5 ml contains Panitumumab, a monoclonal antibody. It is used alone or in conjunction with other anticancer medications to treat metastatic colorectal cancer (mCRC). It works by slowing or preventing the growth of cancer cells. As a result, it inhibits the cancer from spreading.

Side Effects of Vectibix 100 mg Infusion 5 ml

  • Paronychia (nail inflammation)
  • Fatigue
  • Nausea
  • Diarrhea
  • Stomatitis (inflammation and redness of the oral mucosa)
  • Mucosal inflammation
  • Asthenia (abnormal physical weakness)
  • Anorexia
  • Hypomagnesemia
  • Hypokalemia
  • Rash
  • Skin rash
  • Pruritus
  • Feeling sick
  • Dry skin

Directions for Use

Vectibix 100 mg Infusion 5 ml will be administered by a trained and experienced oncologist.

Storage

Store in a cool and dry place away from sunlight

Drug Warnings

Before taking Vectibix 100 mg Infusion 5 ml, inform your doctor about your medical history and ongoing therapies to rule out potential adverse effects or interactions. The dosage of this medicine will be based on your health condition. Your doctor may adjust your dose during therapy based on the treatment results. Vectibix 100 mg Infusion 5 ml may cause infusion reactions, interstitial lung disease (ILD), ocular toxicity, and dermatologic or soft tissue toxicity. Hence, inform the doctor immediately if you suffer any side effects. If therapy needs to be stopped, your doctor will make that decision. Vectibix 100 mg Infusion 5 ml is recommended not to be used in pregnant women. Therefore, if you become pregnant while on treatment with Panitumumab, tell your doctor immediately. Breastfeeding is not recommended while taking panitumumab. Alcohol should be avoided during treatment with this medicine. Drive only if alert, as the Vectibix 100 mg Infusion 5 ml may cause nausea or tiredness.

Therapeutic Class

MONOCLONAL ANTIBODIES

Drug-Drug Interactions

verifiedApollotooltip
PanitumumabAmiodarone
Severe

Drug-Food Interactions

verifiedApollotooltip
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.

Diet & Lifestyle Advise

  • After your treatment begins, several dietary adjustments can help you control side effects.
  • Anyone suffering from a chronic illness, including cancer, should consume foods high in protein, healthy fats, whole grains, and vitamins and minerals.
  • Plant-based proteins are among the best meals to take during chemotherapy or other cancer treatments. They have the highest concentrations of vitamins and minerals, such as nuts, seeds, beans, and legumes.
  • Eat a healthy diet and exercise regularly to maintain a proper weight.
  • Include leafy vegetables, citrus fruits, fatty fish, berries, yogurt, apples, peaches, cauliflower, cabbage, broccoli, beans, and herbs.
  • De-stress yourself by meditating, reading books, taking a warm bubble bath, or listening to soothing music.
  • Performing yoga may also help improve both physical and mental health.
  • Maintain a healthy weight by performing regular low-strain exercises and eating healthy food.
  • Get optimal sleep; rest well.
  • Avoid smoking and alcohol consumption.
  • Avoid fast and fried foods, processed meats, refined carbs, and added sugars.

Habit Forming

No

How Vectibix 100 mg Infusion 5 ml Works

Vectibix 100 mg Infusion 5 ml contains Panitumumab, which works by slowing or stopping the growth of cancer cells. As a result, it prevents the cancer from spreading.

What if I have taken an overdose of Vectibix 100 mg Infusion 5 ml

As Vectibix 100 mg Infusion 5 ml is a parenteral formulation administered by experienced medical staff, the chance of overdose may be less. However, if you think there has been an overdose or experiencing any adverse events, get medical care right away.
bannner image

Alcohol

Unsafe

Do not consume alcohol while on treatment with Vectibix 100 mg Infusion 5 ml.

bannner image

Pregnancy

Unsafe

Vectibix 100 mg Infusion 5 ml is not recommended for use during pregnancy. So, inform your doctor if you are pregnant or suspect pregnancy. You or your partner must use a reliable form of contraception for at least two months from the last dose of medicine to prevent pregnancy while taking these medications.

bannner image

Breast Feeding

Unsafe

Do not breastfeed your baby during the period over which you are being treated with Vectibix 100 mg Infusion 5 ml and for two months after the last dose.

bannner image

Driving

Caution

Vectibix 100 mg Infusion 5 ml will be administered to hospitalized patients. Hence, driving is not recommended.

bannner image

Liver

Caution

If you have a pre-existing or a history of liver disease, inform your doctor before taking Vectibix 100 mg Infusion 5 ml. Your doctor will weigh the benefits and potential risks before prescribing Vectibix 100 mg Infusion 5 ml.

bannner image

Kidney

Caution

If you have a pre-existing or a history of kidney disease, inform your doctor before taking Vectibix 100 mg Infusion 5 ml. Your doctor may titrate the dose if required based on your condition.

bannner image

Children

Caution

The safety and effectiveness of Vectibix 100 mg Infusion 5 ml in children have not been established.

Country of origin

India

Manufacturer/Marketer address

24-25 Floor, One Horizon Center Golf Course Road, Dlf Phase 5 Gurgaon 122002, India.
Other Info - VEC0029

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Vectibix 100 mg Infusion 5 ml is used to treat Metastatic colorectal cancer (mCRC).
Vectibix 100 mg Infusion 5 ml contains Panitumumab, which works by slowing or stopping the growth of cancer cells. Thus, it prevents the cancer from spreading.
Attend all your doctor's appointments while receiving Vectibix 100 mg Infusion 5 ml to ensure the therapy is effective. Regular blood tests and weight checks must be performed. While taking the Vectibix 100 mg Infusion 5 ml, both men and women should use an effective means of contraception. Do not use any other medications unless prescribed by the doctor.
Magnesium and calcium levels in the blood may significantly fall as a result of Panitumumab. Laboratory testing may be recommended by your doctor both before and during treatment.
Some dietary changes can help you manage side effects; for example, in case of diarrhoea-Choose foods or drinks with sodium (sports drinks or broth) and potassium (bananas and all-natural fruit juices).

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
icon image

Keep Refrigerated. Do not freeze.Prepaid payment required.

Add to Cart